💊 दवाएँ A-Z 🧬 लक्ष्य 🛠 उपकरण 📚 मार्गदर्शिकाएँ
सभी दवाएँ दवा वर्ग चिकित्सीय क्षेत्र दुष्प्रभाव
मार्गदर्शिकाएँ शब्दकोश समयरेखा
तुलनाएँ दवाओं की यात्राएँ दवा परिवार
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Zaleplon

CHEMBL1521 Phase 4 अनुमोदित Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
305.3 g/mol
LogP
1.0
Phase
4

This non-benzodiazepine sleep aid is prescribed for the short-term treatment of insomnia, specifically to help people fall asleep faster. It works by binding to GABA receptors in the brain in a way similar to benzodiazepines, producing a calming, sleep-inducing effect. Its very short duration of action means it is less likely to cause next-morning grogginess, but complex sleep behaviors (such as sleepwalking) have been reported.

आणविक भार

305.3300 g/mol

LogP

1.00

TPSA

74.30 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

HIV/एड्स अग्नाशय कैंसर अनिद्रा उच्च रक्तचाप ओवेरियन कैंसर कोलोरेक्टल कैंसर जनरलाइज़्ड एंग्ज़ाइटी डिसऑर्डर थायरॉइड कैंसर नॉन-स्मॉल सेल लंग कैंसर प्रोस्टेट कैंसर मिर्गी (एपिलेप्सी) मूत्राशय कैंसर मोटापा सिज़ोफ्रेनिया स्तन कैंसर

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1

                

                

                
                

                    
InChI

                    
InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3

                

                

                

                    
                    

                        
Molecular Formula

                        
C17H15N5O

                    

                    
                    

                        
HBD / HBA

                        
- / 4

                    

                    
                    

                        
घूर्णनीय बंधन

                        
3

                    

                    
                    
                    

                        
भारी परमाणु

                        
23

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
अक्सर पूछे जाने वाले प्रश्न

                

                    
                    

                        
                        

                            
This non-benzodiazepine sleep aid is prescribed for the short-term treatment of insomnia, specifically to help people fall asleep faster. It works by binding to GABA receptors in the brain in a way similar to benzodiazepines, producing a calming, sleep-inducing effect. Its very short duration of action means it is less likely to cause next-morning grogginess, but complex sleep behaviors (such as sleepwalking) have been reported.

                        

                    

                    

                    

                    

                    

                    

                        
                        

                            
Yes, Zaleplon is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL1521.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 5719.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
चिकित्सा अस्वीकरण

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.